Cargando…

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies

Cognitive impairment is a common feature in Parkinson's disease (PD) and other α-synucleinopathies as 80% of PD patients develop dementia within 20 years. Early cognitive changes in PD patients present as a dysexecutive syndrome, broadly characterized as a disruption of the fronto-striatal dopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trošt, Maja, Perovnik, Matej, Pirtošek, Zvezdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868095/ https://www.ncbi.nlm.nih.gov/pubmed/31798525 http://dx.doi.org/10.3389/fneur.2019.01204

Ejemplares similares

Update on the Management of Parkinson's Disease for General Neurologists
por: Pirtošek, Zvezdan, et al.
Publicado: (2020)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography
por: Perovnik, Matej, et al.
Publicado: (2022)

Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson’s disease and other synucleinopathies: SMARTSPEECH
por: Kouba, Tomáš, et al.
Publicado: (2022)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
por: Perovnik, Matej, et al.
Publicado: (2022)

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
por: Alecu, Irina, et al.
Publicado: (2019)

Timed Up and Go Test With a Cognitive Task: Correlations With Neuropsychological Measures in People With Parkinson’s Disease
por: Çekok, Kübra, et al.
Publicado: (2020)

Endoplasmic Reticulum-Based Calcium Dysfunctions in Synucleinopathies
por: Kovacs, Gergo, et al.
Publicado: (2021)

Skin Biopsy as a Diagnostic Tool for Synucleinopathies
por: Waqar, Sara, et al.
Publicado: (2023)

Neuropsychological effects of deep brain stimulation for Parkinson's disease
por: Harati, Ali, et al.
Publicado: (2013)

Editorial: Brain hemispheric specialization and its pathological change revealed by neuroimaging and neuropsychology
por: Sarica, Alessia, et al.
Publicado: (2022)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

Sex differences in alpha-synucleinopathies: a systematic review
por: Raheel, Kausar, et al.
Publicado: (2023)

Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study
por: Rus, Tomaž, et al.
Publicado: (2022)

Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia
por: Rus, Tomaž, et al.
Publicado: (2022)

Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly
por: Zaccai, Julia, et al.
Publicado: (2015)

Intrastriatal injection of Parkinson’s disease intestine and vagus lysates initiates α-synucleinopathy in rat brain
por: Yang, Zhaofei, et al.
Publicado: (2023)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
por: Miller, Sean J., et al.
Publicado: (2022)

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
por: Ebrahimi-Fakhari, Darius, et al.
Publicado: (2013)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Neural Correlates of Transient Mal de Debarquement Syndrome: Activation of Prefrontal and Deactivation of Cerebellar Networks Correlate With Neuropsychological Assessment
por: Jeon, Seung-Ho, et al.
Publicado: (2020)

Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study
por: Izumi, Yuishin, et al.
Publicado: (2018)

Neuropsychological and Neuropsychiatric Concerns for Deep Brain Stimulation in Dystonia: Preoperative Profiles in a Deep Brain Stimulation Cohort and Postoperative Changes in Three Case Series Reports
por: Zacharia, Sophie J, et al.
Publicado: (2018)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
por: Gao, Fei, et al.
Publicado: (2022)

Wavelet Analysis Increases Sensitivity and Specificity of Spirography for Ambulatory Tremor Discrimination
por: Kragelj, Veronika, et al.
Publicado: (2014)

Semi-Automatic Signature-Based Segmentation Method for Quantification of Neuromelanin in Substantia Nigra
por: Zupan, Gašper, et al.
Publicado: (2019)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
por: Sarkar, Souvarish, et al.
Publicado: (2020)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
por: Flores-Leon, Manuel, et al.
Publicado: (2023)

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease
por: Eisinger, Robert S., et al.
Publicado: (2019)

SWADESH: a multimodal multi-disease brain imaging and neuropsychological database and data analytics platform
por: Mandal, Pravat K., et al.
Publicado: (2023)

Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies
por: Skorvanek, Matej, et al.
Publicado: (2018)

Headache Because of Problems with Teeth, Mouth, Jaws, or Dentures in Chronic Temporomandibular Disorder Patients: A Case–Control Study
por: Ostrc, Tadej, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5uf12lr31bsgahnagpanc0ns8